Krystal Biotech, Inc. (KRYS)
234.64
+0.59
(+0.25%)
USD |
NASDAQ |
Dec 09, 16:00
241.50
+6.86
(+2.92%)
Pre-Market: 08:56
Krystal Biotech EPS Diluted (Quarterly): 2.660 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| Vanda Pharmaceuticals, Inc. | -0.3822 |
| ADMA Biologics, Inc. | 0.1489 |
| Aldeyra Therapeutics, Inc. | -0.1279 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 79.36M |
| Revenue (Quarterly) | 97.80M |
| Total Expenses (Quarterly) | 18.44M |
| Enterprise Value | 6.082B |
| Gross Profit Margin (Quarterly) | 94.21% |
| Profit Margin (Quarterly) | 81.15% |
| Earnings Yield | 2.84% |
| Operating Earnings Yield | 2.26% |
| Normalized Earnings Yield | 2.841 |